VYNE Therapeutics Inc. SC 13D and SC 13D/A reports

Location
685 Route 202/206 N., Suite 301, Bridgewater, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
5/10/2024, 04:10 AM
Form type Sec Links Description Filing date Reporting date
SC 13D Report SC 13D Nov 13, 2023
SC 13D/A Report Apr 16, 2020
SC 13D Report VENBIO GLOBAL STRATEGIC FUND II, L.P. - MENLO THERAPEUTICS INC. -- SCHEDULE 13D Feb 8, 2018